<PAGE> 1
EXHIBIT 23.4
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We hereby consent to the incorporation by reference in this registration
statement of our reports dated February 16, 2000, except for Note 20, which is
as of March 31, 2000, relating to the consolidated financial statements and
schedule of Schein Pharmaceutical, Inc. appearing in the Schein Pharmaceutical,
Inc. Annual Report on Form 10-K for the year ended December 25, 1999 and the
consolidated financial statements of Schein Pharmaceutical, Inc. appearing in
the current report on Form 8-K dated September 11, 2000 of Watson
Pharmaceuticals, Inc.
/s/ BDO SEIDMAN, LLP
New York, New York
January 3, 2001
